Human iPSC-Derived Neural Crest Stem Cells Exhibit Low Immunogenicity.

Area of Science:

• Regenerative Medicine
• Immunology
• Stem Cell Biology

Background:

• Induced pluripotent stem cells (iPSCs) are being evaluated for cellular therapy.
• Allogeneic iPSC use requires safety evaluation, including immunogenicity assessment.
• IPSC-derived neural crest stem cells (iPSC-NCSCs) have therapeutic potential but their immunogenicity is unstudied.

Purpose of the Study:

• To assess the immunogenicity of iPSC-NCSCs for potential cellular therapy.
• To evaluate the expression of immune-related antigens and co-stimulatory molecules on iPSC-NCSCs.
• To investigate the functional immune response to iPSC-NCSCs using a mixed lymphocyte reaction.

Main Methods:

• Assessed human leukocyte antigen (HLA) class I and II expression on iPSC-NCSCs.
• Measured co-stimulatory molecule expression on iPSC-NCSCs.
• Conducted one-way mixed lymphocyte reactions with iPSC-NCSCs as stimulator cells.

Main Results:

• iPSC-NCSCs exhibited a non-immunogenic molecular phenotype.
• No detectable proliferation of CD3+ or CD3+CD8+ T cells was observed.
• No significant cytokine production was induced by iPSC-NCSCs.

Conclusions:

• iPSC-NCSCs demonstrate a lack of immunogenicity in vitro.
• The non-immunogenic profile supports the potential use of iPSC-NCSCs in regenerative medicine.
• Further research into iPSC-NCSC safety and efficacy for cellular therapy is warranted.